News
05-04-2012, 07:02 AM
Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression of these genes, Belgian researchers report at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
More... (http://www.news-medical.net/news/20120504/Potential-breast-cancer-patients-for-new-immune-targeting-therapies.aspx)
More... (http://www.news-medical.net/news/20120504/Potential-breast-cancer-patients-for-new-immune-targeting-therapies.aspx)